What is the current Price Target for the Larimar Therapeutics Inc stock?

The average Larimar Therapeutics Inc target price is $18.36. This is 385.71% higher than the current stock price. The highest price target is 1,011.11%, the lowest is 167.20%. 13 Analysts have issued a price target Larimar Therapeutics Inc 2026 .

How high will the Larimar Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Larimar Therapeutics Inc stock will rise. The performance of stocks, including the Larimar Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Larimar Therapeutics Inc stock today?

The performance of Larimar Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Larimar Therapeutics Inc stock fall?

The decline in Larimar Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Larimar Therapeutics Inc Forecast, price target & analysts

$3.61

4.50% today

Nasdaq, Aug 12, 07:17 pm CET

ISIN

US5171251003

Symbol

LRMR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Larimar Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Larimar Therapeutics Inc Classifications & Recommendation:

Buy

94%

Hold

Larimar Therapeutics Inc Price Target

Target Price	$18.36
Price	$3.78
Potential	385.71% register free of charge
Number of Estimates	13

	13 Analysts have issued a price target Larimar Therapeutics Inc 2026 . The average Larimar Therapeutics Inc target price is $18.36. This is 385.71% register free of charge higher than the current stock price. The highest price target is $42.00 1,011.11% register free of charge , the lowest is $10.10 167.20% register free of charge .
	A rating was issued by 18 analysts: 17 Analysts recommend Larimar Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Larimar Therapeutics Inc stock has an average upside potential 2026 of 385.71% register free of charge . Most analysts recommend the Larimar Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.32	-1.96
	57.14%	48.48%
P/E		negative

14 Analysts have issued a Larimar Therapeutics Inc forecast for earnings per share. The average Larimar Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.32	57.14%
2025	$-1.96 48.48% Unlock
2026	$-2.05 4.59% Unlock
2027	$-1.69 17.56% Unlock
2028	$-1.95 15.38% Unlock
2029	$-1.71 12.31% Unlock
2030	$-1.10 35.67% Unlock
2031	$-0.59 46.36% Unlock
2032	$-0.13 77.97% Unlock

Current	-2.54	69.94%
2025	-1.93 23.92% Unlock
2026	-1.84 4.66% Unlock
2027	-2.24 21.74% Unlock
2028	-1.94 13.39% Unlock
2029	-2.21 13.92% Unlock
2030	-3.43 55.20% Unlock
2031	-6.39 86.30% Unlock
2032	-28.51 346.17% Unlock

Larimar Therapeutics Inc...

Current Larimar Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Jun 25 2025
Wedbush	Locked ➜ Locked	Locked	Jun 24 2025
Guggenheim	Locked ➜ Locked	Locked	Jun 24 2025
Baird	Locked ➜ Locked	Locked	Mar 25 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 25 2025
Guggenheim	Locked ➜ Locked	Locked	Mar 25 2025
Truist Securities	Locked ➜ Locked	Locked	Jan 29 2025

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Jun 25 2025
Locked Wedbush: Locked ➜ Locked	Jun 24 2025
Locked Guggenheim: Locked ➜ Locked	Jun 24 2025
Locked Baird: Locked ➜ Locked	Mar 25 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 25 2025
Locked Guggenheim: Locked ➜ Locked	Mar 25 2025
Locked Truist Securities: Locked ➜ Locked	Jan 29 2025

Discover more stocks with a high price target

Alibaba Group Holding Ltd 29.77%

BioNTech SE - ADR 28.36%

Deutsche Telekom 27.84%

PayPal 25.45%

Walt Disney 22.35%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now